Clinical course of recurrent respiratory papillomatosis: Comparison between aggressiveness of human papillomavirus-6 and human papillomavirus-11

Head and Neck

Volumn 37, Issue 11, 2015, Pages 1625-1632

  Tjon Pian Gi, Robin E A ^a,b   San Giorgi, Michel R M ^a,b   Slagter Menkema, Lorian ^a,b   Van Hemel, Bettien M ^a,b   Van Der Laan, Bernard F A M ^a,b   Van Den Heuvel, Edwin R ^a,b   Dikkers, Frederik G ^a,b   Schuuring, Ed M D ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

clinical course; HPV; HPV11; human papillomavirus, HPV6; recurrent respiratory papillomatosis

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 6; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PAPILLOMATOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT RESPIRATORY PAPILLOMATOSIS; RETROSPECTIVE STUDY; TREATMENT RESPONSE; VIRUS INFECTIVITY; AGE DISTRIBUTION; IMMUNOHISTOCHEMISTRY; INCIDENCE; ISOLATION AND PURIFICATION; NEEDLE BIOPSY; NETHERLANDS; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; PROCEDURES; PROGNOSIS; RESPIRATORY TRACT INFECTIONS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX RATIO; UNIVERSITY HOSPITAL; VIROLOGY; YOUNG ADULT;

ADULT; AGE DISTRIBUTION; BIOPSY, NEEDLE; COHORT STUDIES; FEMALE; HOSPITALS, UNIVERSITY; HUMAN PAPILLOMAVIRUS 11; HUMAN PAPILLOMAVIRUS 6; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; NETHERLANDS; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROGNOSIS; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; YOUNG ADULT;

EID: 84944165156     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23808     Document Type: Article

References (37)

1. Mistry N, Wibom C, Evander M,. Cutaneous and mucosal human papillomaviruses differ in net surface charge, potential impact on tropism. Virol J 2008; 5: 118.
2. Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM,. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010; 401: 70-79.
3. Chelimo C, Wouldes TA, Cameron LD, Elwood JM,. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer. J Infect 2013; 66: 207-217.
4. Gillison ML, Alemany L, Snijders PJ, et al., Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis. Vaccine 2012; 30 Suppl 5: F34-F54.
5. Sanchez GI, Jaramillo R, Cuello G, et al., Human papillomavirus genotype detection in recurrent respiratory papillomatosis (RRP) in Colombia. Head Neck 2013; 35: 229-234.
6. Draganov P, Todorov S, Todorov I, Karchev T, Kalvatchev Z,. Identification of HPV DNA in patients with juvenile-onset recurrent respiratory papillomatosis using SYBR Green real-time PCR. Int J Pediatr Otorhinolaryngol 2006; 70: 469-473.
7. Gerein V, Rastorguev E, Gerein J, Draf W, Schirren J,. Incidence, age at onset, and potential reasons of malignant transformation in recurrent respiratory papillomatosis patients: 20 years experience. Otolaryngol Head Neck Surg 2005; 132: 392-394.
8. Wiatrak BJ, Wiatrak DW, Broker TR, Lewis L,. Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope 2004; 114 (11 Pt 2 Suppl 104): 1-23.
9. Moore CE, Wiatrak BJ, McClatchey KD, et al., High-risk human papillomavirus types and squamous cell carcinoma in patients with respiratory papillomas. Otolaryngol Head Neck Surg 1999; 120: 698-705.
10. Gabbott M, Cossart YE, Kan A, Konopka M, Chan R, Rose BR,. Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis. J Clin Microbiol 1997; 35: 3098-3103.
11. Pou AM, Rimell FL, Jordan JA, et al., Adult respiratory papillomatosis: human papillomavirus type and viral coinfections as predictors of prognosis. Ann Otol Rhinol Laryngol 1995; 104 (10 Pt 1): 758-762.
12. Omland T, Akre H, Vardal M, Brøndbo K,. Epidemiological aspects of recurrent respiratory papillomatosis: a population-based study. Laryngoscope 2012; 122: 1595-1599.
13. Kimberlin DW,. Pharmacotherapy of recurrent respiratory papillomatosis. Expert Opin Pharmacother 2002; 3: 1091-1099.
14. Buchinsky FJ, Donfack J, Derkay CS, et al., Age of child, more than HPV type, is associated with clinical course in recurrent respiratory papillomatosis. PLoS One 2008; 3: e2263.
15. Peñaloza-Plascencia M, Montoya-Fuentes H, Flores-Martinez SE, Fierro-Velasco FJ, Peñaloza-González JM, Sánchez-Corona J,. Molecular identification of 7 human papillomavirus types in recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 2000; 126: 1119-1123.
16. Padayachee A, Prescott CA,. Relationship between the clinical course and HPV typing of recurrent laryngeal papillomatosis. The Red Cross War Memorial Children's Hospital experience 1982-1988. Int J Pediatr Otorhinolaryngol 1993; 26: 141-147.
17. Robb PK Jr, Weinberger PM, Perakis H, et al., Association of asthma with clinically aggressive recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 2011; 137: 368-372.
18. McKenna M, Brodsky L,. Extraesophageal acid reflux and recurrent respiratory papilloma in children. Int J Pediatr Otorhinolaryngol 2005; 69: 597-605.
19. Code for proper secondary use of human tissue in the Netherlands, 2002. Available at: www.federa.org. Accessed October 3, 2013.
20. Derkay CS, Malis DJ, Zalzal G, Wiatrak BJ, Kashima HK, Coltrera MD,. A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis. Laryngoscope 1998; 108: 935-937.
21. Dikkers FG,. Treatment of recurrent respiratory papillomatosis with microsurgery in combination with intralesional cidofovir- A prospective study. Eur Arch Otorhinolaryngol 2006; 263: 440-443.
22. Wisman GB, Nijhuis ER, Hoque MO, et al., Assessment of gene promoter hypermethylation for detection of cervical neoplasia. Int J Cancer 2006; 119: 1908-1914.
23. Halmos GB, van der Laan TP, van Hemel BM, et al., Is human papillomavirus involved in laryngeal neuroendocrine carcinoma? Eur Arch Otorhinolaryngol 2013; 270: 719-725.
24. van Dongen JJ, Langerak AW, Brüggemann M, et al., Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17: 2257-2317.
25. Walter SD, Eliasziw M, Donner A,. Sample size and optimal designs for reliability studies. Stat Med 1998; 17: 101-110.
26. Donne AJ, Hampson L, Homer JJ, Hampson IN,. The role of HPV type in recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 2010; 74: 7-14.
27. de Sanjosée S, Diaz M, Castellsagué X, et al., Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007; 7: 453-459.
28. Campisi P, Hawkes M, Simpson K,; Canadian Juvenile Onset Recurrent Respiratory Papillomatosis Working Group. The epidemiology of juvenile onset recurrent respiratory papillomatosis derived from a population level national database. Laryngoscope 2010; 120: 1233-1245.
29. Derkay CS, Hester RP, Burke B, Carron J, Lawson L,. Analysis of a staging assessment system for prediction of surgical interval in recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 2004; 68: 1493-1498.
30. Derkay CS,. Task force on recurrent respiratory papillomas. A preliminary report. Arch Otolaryngol Head Neck Surg 1995; 121: 1386-1391.
31. To T, Stanojevic S, Moores G, et al., Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health 2012; 12: 204.
32. Hawkes M, Campisi P, Zafar R, et al., Time course of juvenile onset recurrent respiratory papillomatosis caused by human papillomavirus. Pediatr Infect Dis J 2008; 27: 149-154.
33. Silver RD, Rimell FL, Adams GL, Derkay CS, Hester R,. Diagnosis and management of pulmonary metastasis from recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg 2003; 129: 622-629.
34. Hasegawa Y, Sato N, Niikawa H, et al., Lung squamous cell carcinoma arising in a patient with adult-onset recurrent respiratory papillomatosis. Jpn J Clin Oncol 2013; 43: 78-82.
35. Ruan SY, Chen KY, Yang PC,. Recurrent respiratory papillomatosis with pulmonary involvement: a case report and review of the literature. Respirology 2009; 14: 137-140.
36. Lee LA, Cheng AJ, Fang TJ, et al., High incidence of malignant transformation of laryngeal papilloma in Taiwan. Laryngoscope 2008; 118: 50-55.
37. Rabah R, Lancaster WD, Thomas R, Gregoire L,. Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatr Dev Pathol 2001; 4: 68-72.